Gland Pharma Limited
GLAND
株式のランク
#3236
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
株価
$33.33
最終同期: 2026-10-19
時価総額
$5.50B
変化（1日）
-0.68%
変化（1年）
52.16%
国
IN
取引 Gland Pharma Limited (GLAND)
カテゴリー
Healthcare
Gland Pharma Limited（GLAND）の配当履歴
Gland Pharma Limited（証券コード：GLAND）は合計で2回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：$38.00
配当利回り（TTM）：0.0066
すべての配当の合計（株式分割調整済み）は：$38.00
配当利回り（TTM）：0.0066
2024から2026までのGland Pharma Limited（GLAND）の配当履歴
年間配当支払い
| 年 | 配当（株式分割調整済み） | 変化 |
|---|---|---|
| 2026 (TTM) | $18.00 | 0.00% |
| 2025 | $18.00 | -10.00% |
| 2024 | $20.00 | 0.00% |
すべての配当支払いの一覧
| 年 | 配当 | 変化 |
|---|---|---|
| 2026 (TTM) | $18.00 | 0.00% |
| 2025 | $18.00 | -10.00% |
| 2024 | $20.00 | 0.00% |
同業他社や競合企業の配当履歴
| 企業 | 配当支払い回数 | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
